TCTR20180806001Not yet recruitingPhase 2
one
Faculty of Medicine Chiang Mai University0 sites72 target enrollmentStarted: August 6, 2018Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Not yet recruiting
- Enrollment
- 72
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 65 Years to 0 N/A (No limit) (—)
- Sex
- All
Inclusion Criteria
- •- Pre-frail
- •-risk of fall have point since 0
- •- age 65 years up
- •-gender both
Exclusion Criteria
- •Exclusion criteria
- •- Immobility
- •- Bed bound
- •- Disability
- •- Severe audio and visual impairment
- •- Uncontrolled disease (Cancer and heart disease)
- •- Neurological disease (Stroke and Parkinson’s disease)
- •- MMSE score <23
- •- Sever depression
- •- Drugs (Psychotropic high dose)
- •- Chronic alcoholism
- •- Other research exercise
Investigators
Similar Trials
Active, not recruiting
Not Applicable
oMedDRA version: 14.0Level: HLGTClassification code 10035227Term: Plasma cell neoplasmsSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2011-001143-70-ESBreno Moreno de Gusmao
Active, not recruiting
Phase 1
.EUCTR2018-003565-33-FRCHU de Clermont-Ferrand120
Active, not recruiting
Phase 1
.EUCTR2016-001341-41-FRCHU de Clermont-Ferrand
Active, not recruiting
Not Applicable
.EUCTR2014-001452-28-FRCHU de Clermont-Ferrand
Active, not recruiting
Phase 1
..EUCTR2018-004411-49-FRCHU de Clermont-Ferrand50